Browse the evidence

Somatic mitochondrial DNA (mtDNA) mutations drive progeroid (premature aging) phenotypes in mammals primarily through the dysfunction of somatic stem cells, rather than through the accumulation of oxidative damage.

Focus on maintaining overall metabolic health and physical activity, which naturally supports mitochondrial function and stem cell health. Do not rely on antioxidant supplements to reverse aging, as evidence suggests they may be ineffective or harmful. The key takeaway is that cellular maintenance (like stem cell health) is more critical than simply neutralizing free radicals.

Using electronically captured routine data (e.g., hospital episode statistics, clinical databases) for health technology assessment via randomised controlled trials is feasible and potentially cheaper than using purpose-designed data, provided clinical symptoms and signs are collected in sufficient detail.

For researchers designing health technology assessments, consider leveraging existing electronic patient records (like hospital episode statistics) to reduce costs and speed up recruitment. However, ensure that the routine data captures detailed clinical symptoms and signs, as administrative codes alone may not suffice for judging clinical effectiveness. Validate your local data systems' capability before committing to this approach.

Poor fetal and infant nutrition (low birth weight) increases the risk of developing Type 2 diabetes in adulthood, likely through programmed insulin resistance and beta-cell dysfunction.

For expectant mothers, maintaining good nutrition and managing blood sugar (if diabetic) is important for the child's long-term metabolic health. For adults with low birth weight, being aware of the increased risk for insulin resistance is prudent.

Higher educational attainment (Years of Schooling) causally protects against Alzheimer's disease.

Education and lifelong learning contribute to protection against Alzheimer's disease. While you cannot change your past education, engaging in cognitively stimulating activities and continuous learning may help build cognitive reserve.

Decreasing TOR pathway signaling in yeast extends chronological life span by inducing a starvation response that increases stress resistance and storage carbohydrate accumulation.

This research in yeast suggests that limiting nutrient availability, specifically amino acids, triggers a survival mechanism (reduced TOR signaling) that extends life by boosting stress resistance. While this is a model organism study, it supports the human health principle that calorie restriction or specific nutrient limitations may promote longevity through conserved biological pathways.

Homozygosity for the minor G allele of the FOXO3A gene (rs2802292) is strongly associated with increased human longevity, conferring approximately twice the protective effect (OR 2.75) compared to the major TT allele.

You cannot change your FOXO3A genotype, but this research highlights that the genetic variants associated with longevity are also linked to better insulin sensitivity and lower risk of chronic diseases like heart disease and cancer. Focus on maintaining high insulin sensitivity through diet and exercise, as this may mimic the metabolic profile associated with the 'longevity genotype' (lower fasting insulin, lower HOMA-IR).

COPD represents an accelerated aging of the lung, characterized by shared mechanisms such as telomere shortening, cellular senescence, and impaired autophagy.

Understanding COPD as accelerated lung aging may open avenues for therapies targeting aging mechanisms (like senolytics or autophagy enhancers) in addition to standard smoking cessation and bronchodilators.

Testosterone replacement therapy has no significant effect on memory, cognitive function, or prostate-specific antigen (PSA) levels in older hypogonadal men over 12 months.

Based on this study, testosterone therapy did not improve memory or cognitive function, nor did it significantly change PSA levels in men without existing prostate disease. Do not expect cognitive benefits from this treatment.

Acromegaly, characterized by excess GH and IGF-I, leads to high bone turnover which can result in bone loss and vertebral fractures, particularly in patients with coexisting hypogonadism.

This paper describes a pathological condition (acromegaly) rather than a fitness intervention. If you have symptoms of acromegaly (excessive growth, jaw/hand changes), seek medical evaluation as it can negatively impact bone health.

Systemic administration of angiogenesis inhibitors (TNP-470, angiostatin, endostatin, Bay-129566, thalidomide) reduces adipose tissue mass and body weight in obese mice by inducing endothelial apoptosis and inhibiting endothelial proliferation, independent of direct adipocyte toxicity.

This research suggests that targeting the blood vessels within fat tissue (angiogenesis) can reduce fat mass. In obese mice, drugs that inhibit blood vessel growth (like TNP-470, angiostatin, endostatin) led to significant weight loss and fat reduction, comparable to leptin treatment. The weight loss was not just due to eating less, as treated mice lost more weight than control mice fed the same amount of food. This indicates a direct effect on fat tissue metabolism or structure. However, these are experimental drugs in mice, not approved human weight loss treatments.

Exercise does not improve the Ankle-Brachial Index (ABI) in patients with intermittent claudication.

Do not expect your Ankle-Brachial Index (a blood pressure ratio) to change significantly with exercise. This test measures arterial blockage, which exercise does not fix. However, your ability to walk will still improve significantly despite the unchanged test score.

FoxO transcription factors promote muscle atrophy by upregulating ubiquitin ligases (atrogin-1/MAFbx and MuRF1) and autophagy genes.

FoxO factors are responsible for breaking down muscle protein. They are inhibited by the IGF1-Akt pathway (activated by training). When Akt is low (e.g., during inactivity or starvation), FoxO is active, leading to muscle loss. To prevent this, maintain resistance training and adequate protein intake.

Hepatocellular carcinoma can develop in patients with nonalcoholic fatty liver disease (NAFLD) even in the absence of cirrhosis, often presenting with larger tumors and poorer prognosis due to lack of surveillance.

If you have fatty liver disease, be aware that liver cancer can develop even without advanced scarring (cirrhosis). Because these cases are often not detected early, it is important to discuss screening options with your doctor, especially if you have other metabolic risk factors like diabetes or obesity.

Maternal consumption of a high-fat diet during gestation and lactation causes hypothalamic inflammation and altered neural projections in offspring, predisposing them to obesity and metabolic disorders.

For expectant mothers, avoiding high-fat diets during pregnancy and breastfeeding may help prevent metabolic programming issues in the child, such as altered brain circuits that regulate hunger.

Relaxation therapies do not significantly reduce blood pressure when compared to active controls or usual care, and should not be recommended for this purpose.

Do not rely on relaxation therapies (like yoga, meditation, or biofeedback) to lower your blood pressure. While they may help with stress, studies show they do not significantly lower blood pressure compared to standard care or other active treatments.

Pharmacological activation of AMP-activated protein kinase (AMPK) in the hypothalamus directly stimulates food intake in rodents.

This study identifies AMPK in the hypothalamus as a key driver of hunger. While this is a rodent study using direct brain injections, it suggests that metabolic states which activate AMPK (like low energy availability) signal the brain to increase food intake. For humans, this implies that extreme caloric restriction or metabolic stress might trigger biological hunger responses via this pathway, potentially making long-term adherence difficult.

PPARγ2, but not PPARγ1, plays the key role in adipogenic differentiation, as evidenced by the failure of cells with reduced PPARγ2 to differentiate and the inability of PPARγ1 to restore it.

Not all forms of PPARγ are equal. The specific PPARγ2 isoform is the critical driver of fat cell formation, which has implications for drug design targeting this specific pathway.

Several factors, including KLF2, GATA2/3, Pref-1, TAZ, and SIRT1, negatively regulate adipogenesis by inhibiting PPARγ and C/EBPα expression, thereby preventing the formation of mature adipocytes.

The body has natural 'brakes' on fat cell formation (like Pref-1 and SIRT1). Understanding these can lead to therapies that enhance these brakes to prevent obesity.

Selenium supplementation does not protect against cardiovascular disease or mortality in the general population, despite lower selenium levels being associated with higher risk in observational studies.

Do not take selenium supplements for heart disease prevention. While low levels are associated with higher risk, trials show supplements do not reduce that risk.

Long-term CPAP adherence for Obstructive Sleep Apnea (OSA) remains persistently low (~34% non-adherence) over a 20-year period, with no clinically significant improvement despite technological advances and behavioral interventions.

If you have been prescribed CPAP for sleep apnea, be aware that long-term adherence is difficult and typically drops to around 4.5 hours per night for most people, regardless of how new or quiet the machine is. Behavioral support can help add about an hour of use, but it rarely solves the problem entirely. Do not rely on how you feel you are using it; check the machine data. If you cannot tolerate CPAP after trying behavioral strategies, discuss alternative treatments with your provider, as the 'gold standard' label may not apply to your specific case.

Genetic deficiency or pharmacological inhibition of the NLRP3 inflammasome (specifically Nlrp3, ASC, or Caspase-1) protects against high-fat diet-induced obesity and insulin resistance by reducing adipose tissue inflammation, lowering pro-inflammatory cytokines (IL-1β, IL-18), and increasing energy expenditure.

This research suggests that chronic low-grade inflammation in fat tissue, driven by the NLRP3 inflammasome, plays a key role in obesity and insulin resistance. While this is an animal study, it implies that targeting inflammatory pathways (like IL-1β) might help treat obesity and diabetes, independent of just reducing calorie intake. It highlights that obesity is an active inflammatory disease, not just a storage issue.

Genetic overexpression of the autophagy-related gene Atg5 in mice extends median lifespan by approximately 17% and promotes leanness through enhanced autophagic flux, improved insulin sensitivity, and reduced oxidative stress.

This research demonstrates that enhancing autophagy, specifically through the Atg5 pathway, can significantly extend lifespan and improve metabolic health in mice. While direct genetic manipulation is not currently an option for humans, these findings support the potential benefits of lifestyle interventions that naturally boost autophagy, such as caloric restriction or intermittent fasting, which are known to activate similar pathways. The key takeaway is that maintaining cellular cleanup mechanisms (autophagy) is crucial for longevity and metabolic efficiency.

Inhibition of Errα using the synthetic inverse agonist XCT790 reduces PGC-1α-mediated cellular respiration and OXPHOS gene expression in muscle cells.

This study uses a specific drug (XCT790) to block Errα, proving that Errα is necessary for mitochondrial energy production. This supports the hypothesis that activating Errα (rather than blocking it) could be a therapeutic strategy for diabetes.

In Type 1 Diabetes, hyperglucagonemia (excess glucagon) is the primary cause of hyperglycemia and catabolic symptoms, rather than insulin deficiency alone.

For Type 1 Diabetics, managing blood sugar requires addressing high glucagon levels, not just injecting more insulin. Current insulin monotherapy often fails to suppress glucagon without causing hypoglycemia elsewhere. Therapies that suppress glucagon (like somatostatin analogs or leptin) may offer better stability than insulin alone.